Elevance Health (WBO:ELV) Other Stockholders Equity: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ELV Elevance Health Inc WBO:ELV
78 GF Score
Price €321.40
GF Value €431.17
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Elevance Health Other Stockholders Equity?

Elevance Health WBO:ELV -1.86% 78 Other Stockholders Equity is €0 Mil as of Jun. 2026. GuruFocus rates WBO:ELV with a GF Score™ of 78/100 and a GF Value™ of €431.17 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Elevance Health's Other Stockholders Equity for the quarter that ended in Jun. 2026 was €0 Mil.

Elevance Health's quarterly Other Stockholders Equity declined from Dec. 2025 (€0 Mil) to Mar. 2026 (€0 Mil) but then stayed the same from Mar. 2026 (€0 Mil) to Jun. 2026 (€0 Mil).

Elevance Health's annual Other Stockholders Equity stayed the same from Dec. 2023 (€0 Mil) to Dec. 2024 (€0 Mil) but then increased from Dec. 2024 (€0 Mil) to Dec. 2025 (€0 Mil).

Elevance Health Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Elevance Health's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Other Stockholders Equity Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 0.00

Elevance Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
WBO:ELV
78GF Score
Elevance Health Inc WBO:ELV
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €0 Mil mean?
Elevance Health (WBO:ELV) has a Other Stockholders Equity of €0 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Elevance Health and its competitors.
Is Elevance Health's Other Stockholders Equity too high?
Elevance Health's current Other Stockholders Equity is €0 Mil. Overall, Elevance Health has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Other Stockholders Equity compare to CI and HUM?
Elevance Health's Other Stockholders Equity of €0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Plans company?
A good Other Stockholders Equity depends on the Healthcare Plans industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Elevance Health and its competitors. Elevance Health's current Other Stockholders Equity is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €431.17, compared to a current price of €321.40 — trading 25.5% below its estimated fair value. The current Other Stockholders Equity is €0 Mil. Elevance Health's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current Other Stockholders Equity is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (WBO:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €321.40 is trading 25.5% below its estimated GF Value™ of €431.17. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for WBO:ELV:

  • Other Stockholders Equity: €0 Mil
  • GF Value™: €431.17 vs. price of €321.40 (25.5% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
78GF Score

Get the complete analysis for WBO:ELV

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€321.40
Price
€431.17
GF Value